All Articles

A new report reveals a massive gap between what shoppers expect and what stores deliver, costing retailers billions. Can AI-powered smart carts close the divide?

Private equity giant CD&R is deploying capital differently, investing $4.5M in five diverse NYC non-profits. It's a strategic play beyond simple charity.

MEXC’s SpaceX products see $7.1B in trading, tapping huge retail demand. But as crypto bridges to Wall Street, is it building on solid ground or regulatory quicksand?

The government's new National Food Security Strategy is more than a funding announcement; it's a systemic overhaul aiming to fix a fragile food system.

PowerBank secures $4.2M from new institutional investors, earmarking funds for critical U.S. federal projects and military energy independence.

A landmark acquisition pairs a powerful AI engine with deep human expertise, signaling a new era for how brands connect with diverse audiences.

xTool's new O1 Omni Printer combines four industrial printing methods into one desktop unit, aiming to revolutionize production for small businesses and creators.

OrangeX's shift to WOWX is more than a name change. It's a high-stakes gamble on compliance, hype, and a new trading philosophy. But will it work?

Kite Realty Group is executing a sophisticated financial maneuver, refinancing debt to cut costs while buying back shares—a dual strategy that signals confidence.

Kennametal's appointment of Amanda Cole as CHRO isn't just a leadership shuffle. It is a calculated response to the seismic shifts reshaping the industrial sector.

A landmark deal with Croatia's Orqa not only builds Canada's drone industry but also makes it the first non-EU nation to join Europe's SAFE defense initiative.

A new study reveals how Salipro Biotech's platform makes 'undruggable' membrane proteins accessible, a milestone that could reshape pharmaceutical R&D.

Eminent Gold is betting on advanced geophysics to unlock a new Carlin-style gold system in Nevada. New data reveals prime targets for a massive drill program.

Using advanced airborne geophysics, Eminent Gold has pinpointed key drill targets in Nevada, de-risking a major program. Is this the start of a new gold trend?

Cytonics completes a key safety trial for its novel osteoarthritis drug, CYT-108. But the real story is a masterclass in strategic innovation.

GRAIL's revolutionary cancer test failed a key trial, wiping out billions and sparking a fraud lawsuit. A deep dive into the fallout for investors and science.

An investigation into nursing home giant Ensign reveals a troubling intersection of high finance, regulatory loopholes, and the vulnerable lives in its care.

How a services giant tamed 18,000 vendor records to slash risk and build a scalable foundation for future growth and AI-driven operations.

Barry Diller wants to buy MGM Resorts, a company where he's a director. Now, a legal probe is asking if the deal serves all shareholders or just one.

A securities fraud lawsuit against Peabody Energy alleges a classic tale of corporate overpromise, exposing the risks of opaque disclosures in a volatile market.